Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

INDIAN JOURNAL OF DERMATOLOGY, published by Wolters Kluwer Medknow Publications, is a renowned open-access journal that has been a significant platform for disseminating vital research in the field of dermatology since its inception in 1962. With an ISSN of 0019-5154 and an E-ISSN of 1998-3611, the journal covers a comprehensive array of topics relevant to skin health and diseases, serving both academic and clinical audiences in India and beyond. Having transitioned to an open access model in 2005, it strives to enhance the reach and impact of dermatological research. The journal is classified in the Q3 quartile within the dermatology category as of 2023 and ranks 82 out of 142 in Scopus, showcasing its contribution to the field despite competitive rankings. By fostering scholarly communication and providing a rigorous peer-review process, the INDIAN JOURNAL OF DERMATOLOGY remains a vital resource for researchers, practitioners, and students devoted to advancing the understanding and treatment of skin disorders.

The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.

SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

EXPERIMENTAL DERMATOLOGY, published by WILEY, is a leading journal in the fields of Biochemistry and Dermatology, with impressive rankings including Q1 status in both categories as of 2023. With its ISSN 0906-6705 and E-ISSN 1600-0625, the journal offers a reputable platform for disseminating cutting-edge research and insights into skin biology and related health issues. As a pivotal resource for professionals, researchers, and students alike, EXPERIMENTAL DERMATOLOGY includes a broad scope of topics, fostering a deeper understanding of dermatological conditions and enhancing new therapeutic strategies. The journal’s distinguished performance is highlighted by its Scopus rankings, which place it at the 91st percentile in Medicine-Dermatology and the 65th in Biochemistry. While not an open-access publication, the journal remains committed to ensuring the accessibility of crucial developments within the dermatological community worldwide, facilitating the advancement of both clinical practice and academic inquiry.

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

Current Dermatology Reports is a distinguished journal published by SPRINGER that focuses on the latest advancements and research in the field of dermatology. With an ISSN of 2162-4933, this journal provides a vital platform for clinicians, researchers, and students to disseminate groundbreaking findings and emerging trends pertinent to skin health. Notably recognized within the Q2 category in Dermatology for 2023, it ranks 50th out of 142 journals in the Scopus database, placing it in the 65th percentile among its peers. This accessible journal, which has been converging scholarly contributions since its establishment in 2012, plays a crucial role in bridging the gap between clinical practice and research, thereby enhancing patient care and advancing scientific understanding of skin-related issues. The editorial team is committed to the rigorous peer-review process, ensuring high-quality publications that reflect the evolving landscape of dermatology. Researchers and healthcare professionals are invited to contribute and engage with content that pushes the boundaries of knowledge in this dynamic discipline.

AKTUELLE DERMATOLOGIE is a distinguished journal in the field of Dermatology, published by GEORG THIEME VERLAG KG in Germany. With a commitment to advancing knowledge and practice in dermatological science, the journal has regularly featured research articles, reviews, and case studies since its inception in 1975 and continues to publish contributions through 2024. Despite being categorized in the lower quartile (Q4) of dermatology journals and holding a Scopus rank of #127 out of 142, it plays a pivotal role in disseminating valuable insights that support ongoing education and research in the discipline. The journal provides an essential platform for both seasoned professionals and budding researchers to share their findings, explore emerging trends, and discuss clinical practices, all while serving the needs of an evolving medical landscape. Access to its content may be restricted, but the journal remains a crucial reference for those invested in the future of dermatological research and patient care.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, published by Wiley, is a prominent periodical in the field of dermatology, recognized by its Q2 quartile ranking in the 2023 dermatology category. With a dedicated focus on advancing knowledge in dermatological science, the journal publishes rigorous peer-reviewed research that encompasses a range of topics including clinical studies, research methodologies, and innovative treatment practices in dermatology. Its impact is reflected in its Scopus ranking, where it stands at #48 out of 142 in the medicine dermatology category, placing it in the top 66th percentile. Although not an Open Access journal, it serves as a critical resource for researchers, clinicians, and students alike, facilitating the dissemination of high-quality research findings and fostering a deeper understanding of dermatological conditions and treatments. With years of convergence from 2003 to 2024, this journal remains a vital platform for scholarly dialogue and discovery in dermatology.